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Introduction: Cigarette smoking is common among adults with chronic pain. The primary objective of this study
was to determine the period prevalence of smoking in patients with chronic pain. A secondary objective was to
determine the prevalence of smoking among patients with commonly occurring pain diagnoses including
fibromyalgia, low back pain, and headache.
Methods: This population study included 5350 patients (1256 smokers, 4094 nonsmokers) admitted to the Mayo
Comprehensive Pain Rehabilitation Center from January 1998 through December 2012. Smoking status was
determined using a self-report questionnaire.
Results: During the 15 year study period, the overall prevalence of smoking was 23.5 % (95 % CI 22.4 – 24.6). The
prevalence of smoking in 2000, 2005, and 2010 was 24.2, 25.7, and 28.3 % respectively. The overall prevalence of
smoking in patients with fibromyalgia, low back pain, and headache was 25.2 % (95 % CI 22.8 – 28.3), 22.8 %
(95 % CI 21.3 – 25.9), and 21.2 % (95 % CI 17.9 – 24.7), respectively. In a multiple variable logistic model adjusted
for age and sex, opioid use was significantly associated with status as a current smoker.
Conclusion: The prevalence of smoking in patients with chronic pain has not declined when compared to the
general population. The higher prevalence of smoking was consistently observed in commonly occurring pain
diagnoses including fibromyalgia, back pain, and headache. Further research is needed to identify the potential
factors that contribute to the high prevalence of smoking in this patient population.
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The single greatest preventable cause of death in the
United States is cigarette smoking [7]. The health impli-
cations of smoking in chronic pain conditions remains
complex, but several studies have shown positive associ-
ations [4, 11, 20, 26, 28, 31, 41]. For example, smokers re-
port greater pain intensity and a greater number of painful
sites compared to nonsmokers [19, 36]. In addition,
smokers with chronic pain admitted to specialty pain
treatment centers report greater levels of functional im-
pairment compared to nonsmokers [10, 14, 38, 39].
The prevalence of smoking in the general population
has declined over the past decade, but is still estimated at
19.3 % [2]. However, the rate of smoking in individuals
with chronic pain appears to remain higher compared to* Correspondence: hooten.william@mayo.edu
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creativecommons.org/publicdomain/zero/1.0/the general population [3, 9, 26, 31]. Therefore, the pri-
mary aim of this study was to determine the period preva-
lence of smoking in patients with chronic pain admitted
to an interdisciplinary pain treatment center from January,
1998 through December, 2012. A secondary aim was to
determine the prevalence of smoking in patients with
commonly occurring pain diagnoses including fibromyal-
gia, chronic low back pain, and headache.
Methods
Study participants
This study was approved by the Mayo Foundation
Institutional Review Board, and all patients provided
prior written consent for use of their medical records for
research purposes. Inclusion criteria included admission
to the Mayo Comprehensive Pain Rehabilitation Center
from January, 1998 through December, 2012, age ≥ 18,
and pain duration ≥ 6-months. Exclusion criteria in-
cluded use of other forms of tobacco besides cigarettesarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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not indicate smoking status were excluded from study
participation. During this time period, 5617 patients
with chronic pain were admitted to the pain treatment
center; 267 patients (4.9 %) were excluded from study
participation due to use of other forms of tobacco and
missing data. The population study was comprised of
5350 individuals (1256 smokers, 4094 nonsmokers).
Study setting
The study setting was a 3-week, outpatient pain rehabili-
tation program. Descriptions of this treatment setting
have been previously reported [14, 17, 18]. In brief, the
primary goal of treatment is restoration of physical and
emotional functioning. A cognitive-behavioral model
serves as the basis for treatment. Patients referred for
this type of therapy have generally received medical and
surgical care for chronic pain, and experienced incom-
plete symptomatic relief from conventional treatments
including pharmacologic trials, physical therapy, inter-
ventional pain procedures, and surgery. Multidisciplinary
pain treatment differs from independently prescribed
outpatient physical therapy, occupational therapy, and
cognitive-behavioral therapy in that patients are involved
in all these treatment modalities concurrently on a daily
basis throughout the treatment period. Admissions to
the rehabilitation program occur on a revolving basis
and patients attend 8 h daily for 15 consecutive working
days. During the course of treatment, patients are in-
volved in daily physical reconditioning, biofeedback and
relaxation training, stress management, chemical health
education, activity moderation, and elimination of pain
behaviors. Patients are also involved in daily cognitive–
behavioral group educational sessions where the afore-
mentioned aspects of pain rehabilitation are addressed.
Smoking status
Smoking status was assessed upon admission to the pain
treatment center using a self-report questionnaire as
previously described [14, 17]. Incomplete data were avail-
able to categorize never smokers and former smokers into
separate groups; therefore, patients identified as either
never or former smokers were categorized as nonsmokers.
Patients who reported smoking cigarettes upon admission
were categorized as smokers.
Pain diagnosis and pain duration
Upon admission, the primary anatomical site of chronic
pain or underlying pain condition (i.e., fibromyalgia) was
identified and used as the primary pain diagnosis. This
approach for identifying the primary pain diagnosis has
been extensively used in our pain treatment program
[14, 17, 18]. In addition, the duration of chronic pain
was assessed upon admission by self-report and reviewof the medical record. This method of assessing pain
duration has been used extensively in our pain treatment
program [14, 17, 18].
Statistical analyses
The summary statistics for continuous data were re-
ported as an average (± standard deviation; SD), and
categorical data were reported as a number (percent).
The demographics and clinical characteristics (age, sex,
ethnicity, place of residence, pain diagnosis, pain dur-
ation) were summarized for smokers and nonsmokers.
The comparison between smokers and nonsmokers was
made using chi-squared test for categorical variables
and univariate analysis of variance for continuous vari-
ables. The proportion of smokers and nonsmokers in
the year 2000 was compared to the proportion of
smokers and nonsmokers in 2005 and 2010 using chi-
squared tests. Multiple variable logistic regression ana-
lysis was used to assess the potential associations be-
tween smoking status (dependent variable) and opioid
use (independent variable) in a model adjusted for age
and sex. Similarly, multiple variable logistic regression
analysis was used to assess the potential associations
between smoking status and ethnicity in a model ad-
justed for age and sex. For purposes of this particular
analysis, the Hispanic and African American groups
were combined and the “undisclosed” ethnic group was
omitted. Two-sided tests were used in all analyses, and
the level of significance for all statistical tests was set at
P < 0.05. All analyses were completed using JMP
version 9.0.1 (SAS Institute, Cary, NC).
Results
Demographic and clinical characteristics
The population study (n = 5350) was comprised of 1256
smokers and 4094 nonsmokers. The total number of
women was 3812 and the total number of men was 1538
(Table 1). The majority of patients were married Caucasian
women living outside the state of Minnesota. A greater
proportion of nonsmokers were currently employed; other-
wise, no significant differences in demographic or clinical
characteristics based on smoking status were identified.
Prevalence of smoking in adults with chronic pain
During the 15 year study period, the overall prevalence
of smoking was 23.5 % (95 % CI 22.4 – 24.6). The yearly
trend for smoking prevalence ranged from 19.9 to
28.3 % (95 % CI 24.2 – 32.7) (Fig. 1). During the 15 year
study period, the prevalence of smoking among Hispanics
and African Americans was 26.8 % (95 % CI 15.2 – 38.4)
and 19.6 (95 % CI 11.7 – 27.5), respectively. No significant
differences in smoking prevalence were observed when
smoking status was based on sex and stratified by age
(Table 2). Within 5-year intervals starting in 2000, the
Table 1 Baseline demographic and clinical characteristics of
smokers and nonsmokers
Characteristics Smokers Nonsmokers P value*
(n = 1256) (n = 4094)
Age (mean ± SD) 46.3 ± 13.9 45.9 ± 13.5 0.315
Sex (n, %) 0.256
Male 377 (30) 1161 (28)
Female 879 (70) 2933 (72)
Ethnicity 0.625
Caucasian 1072 (85.4) 3517 (86.0)
Hispanic 15 (1.2) 41 (1.0)
African American 19 (1.5) 78 (1.9)
Undisclosed 150 (11.9) 458 (11.1)
Marital status 0.743
Married 786 (63.6) 2546 (63)
Single/Divorce 449 (36.4) 1487 (39)
Residence 0.705
Minnesota 503 (40.1) 1663 (40.7)
Non Minnesota 752 (59.9) 2425 (59.3)
Years of education 14.9 ± 8.4 14.5 ± 3.0 0.918
Currently employed 196 (15.6) 743 (18.1) 0.042
Pain duration, years 9.7 ± 10.2 9.8 ± 10.6 0.763
Primary pain site 0.738
Fibromyalgia 239 (19.0) 700 (17.1)
Low back 317 (25.2) 1030 (25.2)
Headache 117 (9.3) 438 (10.7)
Generalized 132 (10.5) 439 (10.7)
Abdominal 97 (7.7) 315 (7.7)
Neck 92 (7.3) 269 (6.6)
Lower extremity 92 (7.3) 326 (8.0)
Face 30 (2.4) 122 (3.0)
Upper extremity 63 (5.0) 213 (5.2)
Other 77 (6.2) 242 (5.9)
*Chi-square for categorical variable, univariate analysis of variance for
continuous variable
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increased rates was observed starting in the year 2000
(24.2 %) and extending through 2005 (25.7 %) and 2010
(28.3 %) (Fig. 1). However, no significant difference was
observed in the proportion of patients who smoked in
the year 2000 compared to 2005 (P > .1). Similarly, no signi-
ficant difference was observed in the proportion of patients
who smoked in the year 2000 compared to 2010 (P > .1).Prevalence of smoking in diagnostic subgroups
During the 15 year study period, the overall prevalence
of smoking in patients with fibromyalgia, low back pain,and headache was 25.2 % (95 % CI 22.8 – 28.3), 22.8 %
(95 % CI 21.3 – 25.9), and 21.2 % (95 % CI 17.9 – 24.7),
respectively.Associations between smoking status, opioid use, and
ethnicity
In a logistic regression model adjusted for age and sex,
opioid use was significantly associated with status as a
current smoker (odds ratio = 1.4, 95 % CI 1.2 to 1.6,
P = < .001 ). In a logistic regression model adjusted for
age and sex, no significant association was found be-
tween ethnicity and smoking status (odds ratio = 1.0,
95 % CI .99 – 1.1, P = .704).Discussion
The period prevalence of smoking in this group of pa-
tients with chronic pain admitted to an outpatient pain
rehabilitation program over a 15-year period was 23.5 %.
No significant differences in the prevalence of smoking
was observed among subgroups of patients diagnosed
with fibromyalgia, low back pain, or headache. However,
a significant association was observed between opioid
use and status as a current smoker in a multiple variable
regression model adjusted for age and sex.
The prevalence of smoking in the general population
in 2000, 2005, and 2010 was 23.3, 20.9, and 19.3 %, re-
spectively [2, 6]. For the same time periods, the preva-
lence of smoking in our sample of adults with chronic
pain was 24.2, 25.7, and 28.3 %, respectively. Although
fluctuations in the prevalence of smoking occurred dur-
ing the time period of the study, the increasing trend ob-
served in our study compared to the decreasing trend in
the general population could be due, in part, to clinical
characteristics unique to patients with chronic pain in-
cluding concomitant use of opioids. In the current study,
opioid use was significantly associated with status as a
current smoker. This is an important because we have
previously reported that smokers were more likely to
use opioids compared to former and never smokers [15,
16]. In addition, smokers were more likely to consume
greater quantities of opioids due, in part, to use of greater
dosages by men [15]. The association between smoking
and opioid dose occurred independent of key demo-
graphic and clinical characteristics including age, marital
status, years of education, employment status, pain dur-
ation, and pain severity [13, 16]. Previous studies also sug-
gest that it may be more difficult for smokers receiving
long-term opioid therapy to quit smoking [14, 17, 18].
These clinical observations are supported by preclinical
studies that suggest the antinociceptive effects of nicotine
and morphine are linked, and that morphine-related anti-
nociception is influenced by activation of supraspinal nic-
otinic acetylcholine receptors [30, 33, 34].
Fig. 1 The curved line represents the prevalence of smoking in patients with chronic pain. The straight line indicates the prevalence of smoking
in the general population for the years 2000, 2005, and 2010
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ethnicity and smoking status in our study, the prevalence
of smoking among Hispanic and African Americans was
mixed when compared to the general population. For ex-
ample, in the general population the prevalence of smok-
ing among Hispanics in 2000, 2005 and 2010 was 18.6,
16.2, and 12.5 %, respectively [6, 7]. During the 15 year
time period of our study, the prevalence of smoking
among Hispanic adults with chronic pain was 26.8 %
which was higher compared to the general population.
Conversely, in the general population the prevalence of
smoking among African Americans in 2000, 2005, and
2010 was 23.2, 21.5, 18.1 %, respectively [6, 7]. During the
15 year time period of our study, the prevalence of smok-
ing among African Americans was 19.6 %. In previous
studies from our pain treatment center, the prevalence of
smoking among a small group of Hispanic (n = 26) and
African American (n = 22) adults with chronic pain was
11.5 and 31.8 %, respectively [13, 15, 16]. These mixed
data derived from small samples suggest that larger on-
going studies are needed to further investigate the preva-
lence of smoking among Hispanic and African Americans
with chronic pain.
The three most commonly occurring pain diagnoses in
our study sample were fibromyalgia, low back pain, and
chronic headache, and the observed prevalence ofTable 2 Prevalence of smoking based on sex and stratified by age
Characteristics Prevalence (95 % CI*)
Men (n = 1538)
Overall 24.5 (22.4–26.7)
Age group (yrs)
18 – 24 22.2 (14.0–33.1)
25 – 44 25.5 (22.1–29.3)
45 – 64 23.2 (20.2–26.5)
≥ 65 28.1 (21.3–36.0)
*CI = confidence intervalsmoking among patients in these diagnostic groups ex-
tends and confirms the observations of previous studies.
The prevalence of smoking among patients with fibro-
myalgia during the 15 year study period was 25.2 %. In
previous studies, the prevalence of smoking among pa-
tients with fibromyalgia ranged from 9.8 to 25.5 % [23, 25,
27, 39, 40]. Greater impairments in pain-related function-
ing were observed among patients with fibromyalgia who
smoke [39]. Patients in our study were admitted to a
3-week outpatient pain rehabilitation program that spe-
cifically treated individuals with pain-related impair-
ments in functioning which could partly explain the
high prevalence of smoking in our patients with fibro-
myalgia. Smoking is widely recognized to be a risk fac-
tor for chronic low back pain [21, 32]. In previous
studies, the prevalence of smoking in this patient popula-
tion ranged from 16 % to as high as 40 % [5, 22, 24, 36].
The prevalence of smoking during the 15 year study
period in our group of patients with low back pain
(22.8 %) was consistent with these previously reported
observations. Finally, the prevalence of smoking among
patients with chronic headache, including migraine,
ranged from 3 % to as high as 25 to 28 % in previous stud-
ies [1, 8, 29, 35]. During the 15 year study period, our ob-
served prevalence of 21.2 % was consistent with these
previous reports, but direct comparisons are limited byPrevalence (95 % CI) Prevalence (95 % CI)
Women (n = 3812) Total (n = 5350)
23.1 (21.7–24.4) 23.5 (22.4–24.6)
26.2 (20.9–32.3) 25.2 (20.8–30.2)
22.2 (20.2–24.4) 23.1 (21.4–24.9)
22.8 (20.9–25.0) 23.0 (21.3–24.7)
25.3 (21.1–29.9) 26.0 (22.5–29.9)
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ache patients.
This study has limitations. First, the majority of study
participants were Caucasian women residing in the
United States, and all study participants were specifically
referred for pain rehabilitation at a tertiary medical cen-
ter. This is consistent with the referral pattern of our
pain treatment program [12, 15], but it could limit the
generalization of the study findings to other populations
of adults with chronic pain. However, the clinical charac-
teristics of patients admitted to the pain program were
comparable to those of a random sample of community
adults with chronic pain derived from the catchment
area of our medical center [37]. Second, patients were
assigned to 1 of 10 broadly defined diagnostic groups
upon admission to the pain rehabilitation program, but
the specific subtype of pain (e.g., neuropathic, nociceptive)
was not assessed. This could have influenced the preva-
lence of smoking in the defined diagnostic subgroups.
Third, never smokers and former smokers were catego-
rized as nonsmokers. We have previously reported that
significant differences exist between never and former
smokers with chronic pain. More specifically, former
smokers were older, reported longer pain duration, and
were more likely to use daily prescription opioids com-
pared never smokers [13, 15, 16]. The categorization of
never and former smokers as nonsmokers could explain
the absence of significant group differences in the baseline
demographic and clinical characteristics between smokers
and nonsmokers as reported herein. Fourth, the number
of cigarettes smoked daily was not assessed. However, we
have previously reported that smokers admitted to our
pain treatment program consume 14 to 18 cigarettes
daily [15–17].
In summary, the prevalence of smoking in patients
with chronic pain has not declined when compared to
the general population. The high prevalence of smoking
was consistently observed in commonly occurring pain
diagnoses including fibromyalgia, back pain, and head-
ache. The high prevalence of smoking among patients
with chronic pain could be related, in part, to unique
factors that exist in this patient population including
concurrent opioid use.
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